Marion Dorsch, Chief Scientific Officer at Blueprint Medicines Corp (BPMC), sold 7,578 shares at $100.00 ($758K) on 2021-02-22, disclosed to the SEC on 2021-02-24.
Open-market sale of $758k BPMC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BPMC | SELL | 2020-09-25 | $409K | — | Filing → |
| BPMC | SELL | 2020-06-23 | $363K | — | Filing → |
| BPMC | SELL | 2020-03-25 | $64K | — | Filing → |